Overview

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Status:
Terminated
Trial end date:
2019-01-02
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if eltrombopag given in combination with decitabine can help to control advanced MDS. The safety of this study drug combination will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
GlaxoSmithKline
Treatments:
Azacitidine
Decitabine